Daclizumab and Sirolimus to Treat Uveitis

NCT00078689 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

NIH

Sponsor class

Conditions

Uveitis

Interventions

DRUG: Daclizumab

Sponsor

National Eye Institute (NEI)